Table 2

Demographic and clinical outcomes

n=119
Age, mean (SD) years65.0 (10.1)
Post-menopausaln (%)
 Yes107 (89.9)
 No12 (10.1)
WHO performance statusn (%)
 090 (75.6)
 122 (18.5)
 26 (5.0)
 30 (0.0)
 40 (0.0)
 NA1 (0.9)
Stagen (%)
 112 (10.1)
 218 (15.1)
 375 (63.1)
 411 (9.2)
 NA3 (2.5)
Extentn (%)
 Low43 (36.1)
 Moderate34 (28.6)
 High32 (26.9)
 NA10 (8.4)
Management decisionn (%)
 Primary debulking surgery78 (65.5)
 Interval debulking surgery36 (30.3)
 No surgery5 (4.2)
Cytoreduction raten (%)
 Complete73 (61.3)
 Residual <1 cm18 (15.1)
 Residual ≥1 cm2 (1.7)
 Inoperable9 (7.6)
 NA17 (14.3)
 FIGO stage 1 C3 and aboven=110
Received chemotherapyn (%)
 No16 (14.5)
 Yes92 (83.7)
 NA2 (1.8)
  • FIGO, International Federation of Gynecology and Obstetrics; NA, not available.